Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 5633 - 5640 of 12004 results

OIG Opinion Illustrates the Need for New AKS Safe Harbors

October 17, 2018| Blog| Viewpoint

FDA's Drug Centers Release New Draft Guidance on Quantitative Info in Consumer-Directed Ads

October 17, 2018| Blog| Viewpoint

Eleventh Circuit Adjudicates the Delegation Issue with Respect to “Class Arbitrability” No Differently Than for Bilateral Arbitration; but Who Is Bound?

October 17, 2018| Blog| Viewpoint

Trump Administration Proposes Requiring Disclosure of Drug Prices in TV Ads

October 17, 2018| Blog| Viewpoint

Class Arbitrability Questions After 11th Circ. JPay Ruling

October 16, 2018| News

Opportunities for law firms ‘virtually limitless’ with cannabis legalization

October 16, 2018| News

Association Health Plans: Benefits & Challenges

October 15, 2018| Video| Viewpoint

Epidiolex Approval Suggests the Way Forward for Marijuana-Derived Products

October 15, 2018| News

News & Press Releases

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

Mintz Obtains Trademark TRO Against OpenAI on Behalf of IYO, Inc.

June 30, 2025

Mintz secured a rare trademark temporary restraining order (TRO) on behalf of IYO, Inc. against OpenAI, Sam Altman, Sir Jony Ive, and IO Products, Inc. The order temporarily bars the defendants from using the trademark associated with their new product launch.

Mintz Advises Brij in $8M Oversubscribed Funding Round

June 26, 2025

Mintz advised Brij—a software platform enhancing the consumer experience by bridging online and offline commerce—on the closing of its $8 million Series Seed round. The funding will help Brij advance its mission to close the trillion-dollar disconnect between brands and their retail customers and power the next generation of offline-to-online customer relationships.

View all News and Press Releases